Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move comes as the S&P 500 and Nasdaq Composite both slipped slightly. Recursion ...

SALT LAKE CITY - Recursion Pharmaceuticals (NASDAQ: RXRX), a clinical stage company specializing in drug discovery with a market capitalization of $2.28 billion, has received regulatory clearance to ...

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will ...

Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug ...

Abstract: Single Electron Transistor (SET) is a new type of nano - electronic three terminal device which offers the ability to control the motion of individual electrons. It provides current ...

Successfully merging a pull request may close this issue.

In less than four seasons, Luka Doncic finds himself inside the top 10 on the Dallas Mavericks career scoring list. His impact on the franchise goes far beyond. Of those other nine sitting ahead of ...

Abstract: In our paper we investigate the k-ary Algorithm for finding GCD of long natural numbers. We suggest an effective modification for the Algorithm which gives an essential acceleration for the ...